Systematic review examines innate immune recognition and PRR activation in HPV infection and cervical cancer progression.

This systematic review and mini-review focuses on the biological mechanisms underlying human papillomavirus (HPV) infection and cervical cancer within the reproductive tract. The analysis covers innate immune recognition, pattern recognition receptor (PRR) activation, and specific HPV evasion strategies that contribute to disease development. The review details how these interactions lead to the disruption of immune tolerance and subsequent cancer progression. Key secondary outcomes include antiviral defenses, the persistent post-infection microenvironment, impaired antigen presentation, regulatory immune cell infiltration, chronic inflammation, metabolic and stromal remodeling, inflammasomes, type I interferon pathways, and extracellular vesicles.

The review indicates that these complex immunological processes collectively facilitate the transition from infection to malignancy. However, specific numerical data regarding study populations, sample sizes, or quantitative outcomes were not reported in the source material. Consequently, the evidence remains descriptive and mechanistic rather than providing statistical proof of efficacy or risk for specific clinical scenarios. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported as the focus is on biological mechanisms rather than clinical trial interventions.

Key limitations include the lack of reported sample sizes and the absence of specific comparator groups, which restricts the ability to draw definitive causal inferences. The practice relevance of this work lies in its potential to guide the development of more effective immunotherapies, vaccines, and prevention strategies. Clinicians should interpret these findings as a foundation for understanding pathophysiology rather than immediate evidence for changing current management protocols. Further research is needed to translate these mechanistic insights into validated clinical applications.